Ventricular arrhythmias, sudden death, and prevention in patients with hypertrophic cardiomyopathy

Area of Science:

• Cardiology
• Electrophysiology
• Sudden Cardiac Death Research

Background:

• Sudden unexpected death is a devastating complication of hypertrophic cardiomyopathy (HCM), particularly in young, asymptomatic individuals.
• This risk is linked to primary ventricular tachyarrhythmias originating from an electrically unstable myocardial substrate.
• The substrate is characterized by disorganized cellular architecture, ischemia, cell death, and fibrosis.

Purpose of the Study:

• To review the mechanisms of sudden death in hypertrophic cardiomyopathy.
• To discuss current challenges in identifying high-risk HCM patients.
• To highlight available treatment strategies for sudden death prevention in HCM.

Main Methods:

• Review of existing literature on hypertrophic cardiomyopathy and sudden cardiac death.
• Analysis of the pathophysiology of ventricular tachyarrhythmias in HCM.
• Evaluation of the efficacy of implantable cardioverter-defibrillators in HCM patients.

Main Results:

• Ventricular tachyarrhythmias are the primary cause of sudden death in HCM.
• Identifying high-risk individuals remains a clinical challenge.
• Implantable cardioverter-defibrillators demonstrate high efficacy in preventing sudden cardiac death.

Conclusions:

• Sudden death in HCM stems from ventricular tachyarrhythmias in a compromised myocardial substrate.
• While precise risk stratification is difficult, effective preventative therapies exist.
• Implantable cardioverter-defibrillators are crucial for both primary and secondary prevention of sudden cardiac death in HCM.